Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resverlogix Corp | 0.00 | -9.70m | 31.65m | 18.00 | -- | -- | -- | -- | -0.0342 | -0.0342 | 0.00 | -0.4237 | 0.00 | -- | -- | 0.00 | -91.25 | -- | -- | -- | -- | -- | -- | -- | 0.0248 | -1.30 | -- | -- | -- | -- | 54.39 | -- | -- | -- |
| Microbix Biosystems Inc | 16.76m | -4.27m | 31.87m | 69.00 | -- | 1.20 | -- | 1.90 | -0.0308 | -0.0308 | 0.1205 | 0.1917 | 0.4417 | 1.09 | 3.76 | -- | -11.25 | 3.86 | -12.39 | 4.37 | 46.74 | 55.92 | -25.48 | 6.37 | 4.48 | -4.28 | 0.2051 | -- | -26.81 | 12.04 | -163.80 | -- | -0.4115 | -- |
| MustGrow Biologics Corp | 7.54m | -6.37m | 34.00m | 0.00 | -- | 10.93 | -- | 4.51 | -0.1206 | -0.1206 | 0.1435 | 0.0494 | 1.45 | 5.49 | 45.16 | -- | -122.84 | -54.87 | -193.93 | -66.95 | 14.51 | -- | -84.52 | -341.26 | 1.25 | -103.31 | 0.1671 | -- | -91.55 | -- | -622.18 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -39.26m | 40.17m | 22.00 | -- | 0.7648 | -- | -- | -72.87 | -72.87 | 0.00 | 7.24 | 0.00 | -- | -- | 0.00 | -246.96 | -63.88 | -359.42 | -70.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -449.14 | -- | -- | -- |
| ZYUS Life Sciences Corp | 465.00k | -33.74m | 49.92m | 2.00 | -- | -- | -- | 107.37 | -0.4505 | -0.4505 | 0.0062 | -0.1659 | 0.0208 | 0.3346 | 1.17 | -- | -150.55 | -74.90 | -454.68 | -102.81 | 13.12 | 3.61 | -7,256.77 | -8,974.20 | 0.0726 | -9.28 | 6.94 | -- | 37.04 | 313.06 | 20.63 | -- | -- | -- |
| Nurexone Biologic Inc | 0.00 | -8.94m | 59.13m | 9.00 | -- | 26.97 | -- | -- | -0.12 | -0.12 | 0.00 | 0.0242 | 0.00 | -- | -- | -- | -208.79 | -215.30 | -263.35 | -529.63 | -- | -- | -- | -- | -- | -102.73 | 0.0514 | -- | -- | -- | -38.58 | -- | -- | -- |
| Sharp Therapeutics Corp | 0.00 | -9.28m | 67.70m | -- | -- | 34.96 | -- | -- | -4.15 | -4.15 | 0.00 | 0.0645 | 0.00 | -- | -- | -- | -435.86 | -- | -512.62 | -- | -- | -- | -- | -- | -- | -- | 0.477 | -- | -- | -- | -2,282.81 | -- | -- | -- |
| Medicenna Therapeutics Corp | 0.00 | -12.99m | 73.41m | 18.00 | -- | 11.82 | -- | -- | -0.1554 | -0.1554 | 0.00 | 0.0745 | 0.00 | -- | -- | 0.00 | -57.34 | -56.44 | -69.63 | -63.20 | -- | -- | -- | -- | -- | -- | 0.0213 | -- | -- | -- | 53.64 | -- | -- | -- |
Data as of Mar 03 2026. Currency figures normalised to Nurexone Biologic Inc's reporting currency: Canadian Dollar CAD
